Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nurx

Nurx
2015 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$36.2M LATEST DEAL AMOUNT
12 INVESTORS
Description

Provider of a birth control medication prescription and delivery platform intended to put women in control of their own health. The company's platform allows users to request for medications and get delivery without the need to visit a doctor, hospital or consult any medical professional, enabling women to have safe and timely access to birth control.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Other Healthcare Services
Primary Office
  • 9450 South West Gemeni Drive
  • Suite 38105
  • Beaverton, OR 97008
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nurx’s full profile, request a free trial.

Nurx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 06-Dec-2017 $36.2M 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Nov-2016 00.00 00.000 000.00 Completed Generating Revenue
2. Accelerator/Incubator 22-Mar-2016 $120K $120K 00.000 Completed Startup
1. Angel (individual) 15-Sep-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Nurx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 745,944 $0.000010 $0.37 $0.37 1x $0.37 2.5%
Series A-1 4,081,144 $0.000010 $1.18 $1.18 1x $1.18 13.68%
To view this company’s complete Cap Table, request access »

Nurx Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pandia Health Accelerator/Incubator Backed Sunnyvale, CA 0 000000000000
000000 00 000000 Venture Capital-Backed San Francisco, CA 000 00000 00000000000 00000
000 0000 0000 Venture Capital-Backed Redwood City, CA 000 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Nurx Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Clinton Foundation Impact Investing Minority 000 0000 000000 0
Fifty Years Venture Capital Minority 000 0000 000000 0
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
CSC UpShot Ventures Venture Capital Minority 000 0000 000000 0
Lowercase Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Nurx Executive Team (9)

Name Title Board
Seat
Contact
Info
Varsha Rao Chief Executive Officer
Jonathan Czaja Chief Operating Officer
Edvard Engesaeth MD Innovation Officer and Co-Founder
Sheena Deol Executive Assistant
Hans Gangeskar Co-Founder & Board Member

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Nurx Board Members (4)

Name Representing Role Since Contact
Info
Chelsea Clinton Ph.D Clinton Foundation Board Member 000 0000
Hans Gangeskar Nurx Co-Founder & Board Member 000 0000
Noah Knauf Kleiner Perkins Board Member 000 0000
Regina Benjamin MD Nurx Board Member 000 0000